Perrigo Ordinary Shares reported $-65100000 in Net Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbott ABT:US $ 2018M 429M
Abbvie ABBV:US $ 924M 3566M
Bayer BAYN:GR € -298M 3589M
Bristol Myers Squibb BMY:US $ 1421M 143M
Catalent CTLT:US $ 188M 47M
Corcept Therapeutics CORT:US $ 27.41M 4.62M
Dr.Reddys Laboratories DRRD:IN IR 11890M 10920M
Eli Lilly And LLY:US $ 952.5M 950.4M
Endo International Ordinary Shares ENDP:US $ -1885.43M 1813.45M
Horizon Pharma HZNP:US $ 60.97M 143.29M
JAZZ PHA JAZZ:US $ 34.66M 33.02M
Johnson & Johnson JNJ:US $ 4814M 335M
Lannett LCI:US $ -93.3M 58.4M
Merk MRK:US $ 3944M 366M
Pacira Pharmaceuticals PCRX:US $ 19.88M 13.05M
Perrigo Ordinary Shares PRGO:US $ -65.1M 62.7M
Pfizer PFE:US $ 9905M 2042M
Prestige Brands PBH:US $ 55.27M 3.19M
Supernus Pharmaceuticals SUPN:US $ 7.86M 17.75M
Teva Pharmaceutical TEVA:IT -233000000 722M
Xeris Pharmaceuticals Inc XERS:US -26185000 7.53M
Zoetis ZTS:US $ 529M 66M